Papers: 1 May 2015 - 8 May 2015
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
Male rats develop more severe experimental autoimmune encephalomyelitis than female rats: Sexual dimorphism and diergism at the spinal cord level.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS).
Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies.
Immunohistochemical study of Krüppel-like factor 4 in the spinal cords of rats with experimental autoimmune encephalomyelitis.
Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients.
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.
Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
A RARE CASE OF ODONTOGENIC PARAINFECTIOUS INTRAORBITAL OPTIC NEURITIS WITH THE ABSENCE OF CLINICAL MANIFESTATION OF ORBITAL CELLULITIS.
Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF).